It has been known for some time that pantothenic acid is effective as a growth vitamin for many bacteria (Williams, 1943) . The mechanism involved in the effect of pantothenic acid on growth is, however, not known. The present report deals with a study which indicates that pantothenic acid is involved in the synthesis of tryptophane essential for the multiplication of Staphylococcus aureus. Pantothenate alone or in combination with other vitamins likewise exercises a marked effect upon the resistance of staphylococci to sulfonamides. The relationships between these observations will be described in this paper.
M. G. SEVAG AND MORRIS N. GREEN of toxigenic S. aureus which were isolated from the blood in cases of septicemia. accompanying acute osteomyelitis. When we received them they were cultivated on brain-heart-infusion agar. Stoppered with cotton and cork, they- * Synthetic medium: 10 ml of the M/30 phosphate (pH 7.4) solution containing 6.6 X 104 M of alanine, valine, leucine, glycine, proline, oxyproline, aspartic acid, glutamic acid, 2.5 X 1O4 M of methionine, phenylalanine, tyrosine, hydrochlorides of histidine, lysine, 3.36 X 10-8 M of threonine, 3.05 X 10-3 M of isoleucine, 9.0 X 10-4 M of cysteine hydrochloride, 2.5 X 10-4 M of ferrous ammonium sulfate, 1 X 10-3 M of sodium dithiodiglycollate, 3.3 X 10-4 M of magnesium sulfate, 1 ;Lg/ml of medium of each of thiamine chloride and nicotinamide.
t Turbidity readings represent growth per 3 ml culture which was diluted in a standard tube to 10 ml with saline, and the optical density of the suspension was determined with a Mlett-Summerson photoelectric colorimeter. A reading of 66 corresponds to 0.14 mg of staphylococcal nitrogen (or 1 mg of staphylococci) or approximately to 2.5 to 3.5 billion cocci.
Inoculum: Staphylococci grown for 20 hours on 5 ml of slant extract agar were suspended in 60 to 80 ml of saline of which 0.2 ml was added aseptically to 10 ml culture medium. Or they were suspended in 5 ml of saline and a loopful used as inoculum. In either case the reading on the inoculated media was 0 at 0 hour of growth.
t Measurements: 16 to 24 hours after the first appearance of growth.
were kept at room temperature for 10 months before they were subcultured on extract agar and used in growth experiments. Unlike the other 5 nonexacting strains we had gathered from various sources, 3 strains of Blair were found to be partially exacting, and the fourth (B-523) exacting. A fresh culture of 523 (B-523N, table 1) received from Dr. Blair, on the other hand, behaved like a partiaUy exacting strain. In the light of these facts it would seem that the B-523 (b) Both B-523S and B-523SC strains require tryptophane for growth, behaving like exacting strains as defined above. In the absence of tryptophane, pantothenate in a concentration of 0.1 to 1.0 ,pg per ml is necessary before growth is obtained. In the B-523S strain, measurable growth does not appear until after about seven days (pantothenate concentration 1.0 pug per ml). With the B-523SC strain, however, growth appears within three days (pantothenate concentration 0.1 pug per ml). The B-523S strain, upon daily (1) in the absence of the vitamins (section A), the addition of tryptophane to the medium does not appear to antagonize noticeably the inhibition of growth by sulfonamides; (2) the presence of vitamins alone (section B) does not antagonize sulfonamide action in the absence of added tryptophane; and (3) the simultaneous presence of both the vtamins and added tryptophane abolishes the inhibition of the growth by sulfonamides (section B).5
It seems reasonable to conclude that these vitamins exercise a significant role on the glucose tryptophane metabolism in counteracting the antibacterial action of sulfonamides. This role of vitamins appears to be limited (in the case of the strain used) to the utilization of the added tryptophane, and not to its synthesis from glucose and other amino acids. The inhibition of the synthesis of tryptophaie appears to be the critical action of sulfonamides.
Of the vitamins studied, pantothenate and riboflavin exercise the most significant roles. The results (table 2, section C, experiments 1, 2, 3)6 show that only in the presence of added tryptophane is pantothenate alone capable of bringing about, partially or completely, the elimination of the inhibition of growth by sulfonamides. Sulfonamides block the metabolism of glucose leading to the synthesis of tryptophane, and not the utilization of added tryptophane in the presence of pantothenate.
The results of experiments with the partially exacting strain B-523 (table 3, section A) show that the addition of pantothenate to the glucose-free medium ' We are indebted to Dr. R. Major of Merck and Company for a sample of biotin, and to Drs. E. L. R. Stokstad, B. L. Hutchings, and N. Bohonos of Lederle Laboratories for a sample of Lactobacillus casei factor. ' This may raise the question as to whether or not it is advisable to administer vitamins indiscriminately to patients who are undergoing intensive sulfonamide therapy during an infection. The answer to this question must come from clinical observations. Perhaps better results can be obtained by withholding vitamins temporarily.
6 A comparison of the results listed under experiments 1, 2, and 3 with those of experiment 4 shows that the age of the culture used as the inoculum may be an important factor. does not appear to influence the metabolism of added tryptophane in counteracting the inhibition by sulfonamide. However, in the presence of glucose the utilization of tryptophane is promoted by pantothenate and the inhibition by sulfonamides undergoes a certain degree of reduction. A similar effect on the synthesis of tryptophane under these conditions is not apparent (table 3, section B). These observations emphasize the interrelationship of glucose tryptophane pantothenate metabolism.
In experiments with the B-523 strain, on the other hand, the sulfonamideantagonizing action of riboflavin appears to be independent of the presence of glucose if tryptophane is added to the medium. Inhibition under these conditions is not only abolished, but growth increases 38 per cent ( Inability of Staphylococcus aureus to Synthesize Pantothenic Acid as the Possible Mechanism of Variation. In understanding the mechanism of the variation of the staphylococcal strain B-523 the following considerations may be of interest. The ability of the nonexacting strains to grow in tryptophane-free amino acid medium indicates that they are capable of synthesizing tryptophane from other amino acids in the absence of both glucose and pantothenic acid. The partially exacting strain (B-523N) is capable of achieving the same result in the absence of pantothenic acid, but only when glucose is present; whereas the exacting strains (B-523S and B-523SC) require the presence of both pantothenic acid and glucose for the synthesis of tryptophane. These observations indicate that there are several stages in the processes of variation. In the case of the partially exacting strain, the presence of glucose is essential for the synthesis of tryptophane, and therefore for growth. This may indicate that pantothenic acid is readily synthesized by the cell, or is already stored within the cell. In the former case, glucose may be essential for the synthesis of pantothenate, which is then followed by the synthesis of tryptophane. In the latter case, it may be incapable of mediating the synthesis of tryptophane from other amino acids unless glucose is present. In the case of the exacting strain, a further degradation .637 on July 7, 2017 by guest http://jb.asm.org/ Downloaded from has apparently taken place. With this strain, the presence of glucose is inadequate for the synthesis of tryptophane unless pantothenic acid is provided. The loss of the ability to synthesize pantothenic acid therefore appears to be one of the critical changes in the enzyme system of the exacting variant of Staphylococcus aureus.
SUMMARY
Pantothenic acid mediates (a) the metabolism of glucose leading to, or involved in, the synthesis of tryptophane essential for the growth of the exacting strains of Staphylococcus aureus; (b) in the presence of glucose the oxidation of tryptophane to one or more arylamines (not p-aminobenzoic acid); and (c) the glucose tryptophane metabolism in counteracting the inhibitory action of sulfonamides on the utilization of added tryptophane. Hence, the inhibition of the synthesis of tryptophane from glucose and amino acids appears to be the critical action of sulfonamides on S. aureus.
